AcouSort attends Advanced Therapies Week to extend its cell therapy network
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
The Phacilitate Network consists of over 1,800 industry experts within cell and gene therapy. For 20 years, the network has hosted the Advanced Therapies Week for knowledge sharing, relationship building and deal making. January 16-19, AcouSort will attend Advanced Therapies Week for the first time to interface with companies who are working on current and next generation technologies for cell and gene therapy.
The decision to participate in Advanced Therapies Week follows a year where AcouSort made significant advances in the cell therapy area. Current collaborations and discussions have demonstrated that the Company’s technology has a vital role to play in making the manufacturing of cell therapies much more efficient. During the meeting, AcouSort will give a poster presentation on its recently developed high-throughput cell processing solution targeting cell therapy applications.
“Advanced Therapies Week is the primary networking meeting for industry leaders within cell and gene therapy. It specifically focuses on next generation solutions supporting the biotech industry, thus making the event an excellent opportunity to present the fantastic benefits of our technology,” says Torsten Freltoft, AcouSort’s CEO.